Current developments in molecular monitoring in chronic myeloid leukemia.
- Published in:
- Therapeutic Advances in Hematology, 2016, v. 7, n. 5, p. 237, doi. 10.1177/2040620716657994
- By:
- Publication type:
- Article
Works matching IS 20406207 AND DT 2016 AND VI 7 AND IP 5
Results: 5
1
2
Treatment of multiple myeloma with the immunostimulatory SLAMF7 antibody elotuzumab.
- Published in:
- Therapeutic Advances in Hematology, 2016, v. 7, n. 5, p. 288, doi. 10.1177/2040620716657993
- By:
- Publication type:
- Article
3
The potential of venetoclax (ABT-199) in chronic lymphocytic leukemia.
- Published in:
- Therapeutic Advances in Hematology, 2016, v. 7, n. 5, p. 270, doi. 10.1177/2040620716655350
- By:
- Publication type:
- Article
4
The potential of gene therapy approaches for the treatment of hemoglobinopathies: achievements and challenges.
- Published in:
- Therapeutic Advances in Hematology, 2016, v. 7, n. 5, p. 302, doi. 10.1177/2040620716653729
- By:
- Publication type:
- Article
5
Recent advances and novel treatment paradigms in acute lymphocytic leukemia.
- Published in:
- Therapeutic Advances in Hematology, 2016, v. 7, n. 5, p. 252, doi. 10.1177/2040620716652289
- By:
- Publication type:
- Article